19 June 2013
Keywords: astrazeneca, files, zomig, nasal, spray, filed, its
Article | 22 November 2000
AstraZeneca has filed its first regulatory dossier, in Europe, for a newnasal spray formulation of its antimigraine agent Zomig (zolmitriptan)
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 November 2000
23 November 2000
20 November 2000
© 2013 thepharmaletter.com